• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核蛋白特异性非中和抗体可独立于补体和 FcγR 加速 LCMV 的清除。

Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.

机构信息

Department of Immunology, Institute of Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.

出版信息

Eur J Immunol. 2013 Sep;43(9):2338-48. doi: 10.1002/eji.201343565. Epub 2013 Jul 15.

DOI:10.1002/eji.201343565
PMID:23749409
Abstract

CD8(+) T cells have an essential role in controlling lymphocytic choriomeningitis virus (LCMV) infection in mice. Here, we examined the contribution of humoral immunity, including nonneutralizing antibodies (Abs), in this infection induced by low virus inoculation doses. Mice with impaired humoral immunity readily terminated infection with the slowly replicating LCMV strain Armstrong but showed delayed virus elimination after inoculation with the faster replicating LCMV strain WE and failed to clear the rapidly replicating LCMV strain Docile, which is in contrast to the results obtained with wild-type mice. Thus, the requirement for adaptive humoral immunity to control the infection was dependent on the replication speed of the LCMV strains used. Ab transfers further showed that LCMV-specific IgG Abs isolated from LCMV immune serum accelerated virus elimination. These Abs were mainly directed against the viral nucleoprotein (NP) and completely lacked virus neutralizing activity. Moreover, mAbs specific for the LCMV NP were also able to decrease viral titers after transfer into infected hosts. Intriguingly, neither C3 nor Fcγ receptors were required for the antiviral activity of the transferred Abs. In conclusion, our study suggests that rapidly generated nonneutralizing Abs specific for the viral NP speed up virus elimination and thereby may counteract T-cell exhaustion.

摘要

CD8(+) T 细胞在控制小鼠淋巴细胞性脉络丛脑膜炎病毒 (LCMV) 感染中起着至关重要的作用。在这里,我们研究了体液免疫(包括非中和抗体)在低病毒接种剂量诱导的这种感染中的作用。体液免疫受损的小鼠容易终止缓慢复制的 LCMV 株 Armstrong 的感染,但在接种快速复制的 LCMV 株 WE 后,病毒清除延迟,无法清除快速复制的 LCMV 株 Docile,这与野生型小鼠的结果形成对比。因此,控制感染需要适应性体液免疫,这取决于所使用的 LCMV 株的复制速度。Ab 转移进一步表明,从 LCMV 免疫血清中分离的 LCMV 特异性 IgG Ab 加速了病毒清除。这些 Ab 主要针对病毒核蛋白(NP),完全缺乏病毒中和活性。此外,针对 LCMV NP 的 mAb 也能够在转移到感染宿主后降低病毒滴度。有趣的是,转移的 Ab 发挥抗病毒作用既不需要 C3 也不需要 Fcγ 受体。总之,我们的研究表明,针对病毒 NP 的快速产生的非中和 Ab 加速了病毒清除,从而可能对抗 T 细胞耗竭。

相似文献

1
Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.核蛋白特异性非中和抗体可独立于补体和 FcγR 加速 LCMV 的清除。
Eur J Immunol. 2013 Sep;43(9):2338-48. doi: 10.1002/eji.201343565. Epub 2013 Jul 15.
2
Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.非中和抗体通过不激活 FcγR 或补体而独立保护免受慢性 LCMV 感染。
Eur J Immunol. 2013 Sep;43(9):2349-60. doi: 10.1002/eji.201343566. Epub 2013 Jul 15.
3
Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.通过细胞内病毒蛋白的释放证明抗病毒细胞毒性T细胞在体内对感染细胞的裂解作用。
Eur J Immunol. 1993 Jul;23(7):1540-5. doi: 10.1002/eji.1830230722.
4
Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.淋巴细胞性脉络丛脑膜炎病毒感染所致免疫抑制:效应T细胞和B细胞功能正常,但抗原呈递受损。
Eur J Immunol. 1992 Jul;22(7):1803-12. doi: 10.1002/eji.1830220720.
5
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.病毒特异性细胞毒性T细胞对中和抗病毒抗体反应的损害和延迟。
J Immunol. 1993 Nov 15;151(10):5408-15.
6
Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent.阻断 IL-10 可使慢性感染转为 resolved 感染,但依赖于 LCMV 株。
Eur J Immunol. 2013 Mar;43(3):649-54. doi: 10.1002/eji.201242887. Epub 2013 Jan 25.
7
Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.病毒和宿主变量在由非细胞溶解性病毒引起的病毒持续存在或免疫病理疾病中的作用。
J Gen Virol. 1995 Feb;76 ( Pt 2):381-91. doi: 10.1099/0022-1317-76-2-381.
8
Residual LCMV antigen in transiently CD4 T cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory.在短暂性 CD4 T 细胞耗竭的小鼠中,残留的 LCMV 抗原诱导高水平的病毒特异性抗体,但仅产生有限的 B 细胞记忆。
Eur J Immunol. 2019 Apr;49(4):626-637. doi: 10.1002/eji.201847772. Epub 2019 Feb 4.
9
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.淋巴细胞性脉络丛脑膜炎病毒WE株在幼年时的长期感染过程:CD8 +效应T细胞的诱导但扩增有限,且缺乏记忆性CD8 + T细胞。
J Virol. 2007 Jul;81(14):7338-50. doi: 10.1128/JVI.00062-07. Epub 2007 May 9.
10
Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.免疫耐受对 LCMV 抗原的影响不同,会影响小鼠对急性和慢性病毒感染的控制。
Eur J Immunol. 2018 Jan;48(1):120-127. doi: 10.1002/eji.201747156. Epub 2017 Sep 15.

引用本文的文献

1
Themis differentially regulates T follicular helper cell differentiation during early and late stages of chronic viral infection.Themis在慢性病毒感染的早期和晚期对滤泡辅助性T细胞分化进行差异性调控。
Front Immunol. 2025 Jul 24;16:1638178. doi: 10.3389/fimmu.2025.1638178. eCollection 2025.
2
Patrolling monocytes mediate virus neutralizing IgG effector functions: beyond neutralization capacity.巡逻单核细胞介导病毒中和IgG效应功能:超越中和能力。
Front Immunol. 2025 May 29;16:1600056. doi: 10.3389/fimmu.2025.1600056. eCollection 2025.
3
KMT2D coordinates antiviral CD4 T cell responses through opposing effects on T follicular helper and cytotoxic gene expression.
KMT2D通过对滤泡辅助性T细胞和细胞毒性基因表达的相反作用来协调抗病毒CD4 T细胞反应。
Cell Rep. 2025 Jun 24;44(6):115775. doi: 10.1016/j.celrep.2025.115775. Epub 2025 Jun 2.
4
Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis.长期新冠背后的内在因素:探索核衣壳蛋白在血栓形成中的作用
PeerJ. 2025 May 20;13:e19429. doi: 10.7717/peerj.19429. eCollection 2025.
5
Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?细胞表面RNA病毒核衣壳蛋白:一种免疫抑制的病毒策略?
Npj Viruses. 2024 Sep 2;2(1):41. doi: 10.1038/s44298-024-00051-3.
6
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus.复制子颗粒疫苗接种诱导非中和性抗核蛋白抗体介导的克里米亚-刚果出血热病毒控制。
NPJ Vaccines. 2024 May 23;9(1):88. doi: 10.1038/s41541-024-00877-1.
7
Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus.核衣壳蛋白特异性单克隆抗体可保护小鼠免受克里米亚-刚果出血热病毒感染。
Nat Commun. 2024 Feb 26;15(1):1722. doi: 10.1038/s41467-024-46110-4.
8
Protective mechanisms of nonneutralizing antiviral antibodies.非中和性抗病毒抗体的保护机制。
PLoS Pathog. 2023 Oct 5;19(10):e1011670. doi: 10.1371/journal.ppat.1011670. eCollection 2023 Oct.
9
Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.细胞表面核衣壳蛋白表达:一种β冠状病毒免疫调节策略。
Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2304087120. doi: 10.1073/pnas.2304087120. Epub 2023 Jul 3.
10
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell.基于重组核衣壳的新冠病毒疫苗Convacell的免疫原性及体内保护作用
Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874.